Publisher： Adis International
ISSN： 1173-5503
Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.573, 2009-01, pp. : 7-7
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
sHLA-G expression: is it really worth measuring?
By Sher G Keskintepe L Ginsburg M
Reproductive BioMedicine Online, Vol. 14, Iss. 1, 2007-01 ,pp. :
Access to resources
Recommend
Cost sharing of antiasthmatics in children − is it really worth it?
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 651, 2012-01 ,pp. :
Facilitated PCI associated with worse outcomes than primary PCI
Inpharma, Vol. 1, Iss. 1527, 2006-01 ,pp. :
Eptifibatide worthwhile in patients undergoing PCI
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 351, 2002-01 ,pp. :
PCI cost effective for severe angina
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 665, 2012-01 ,pp. :